These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38757573)

  • 1. DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors.
    Guerin N; Childs H; Zhou P; Donald BR
    Protein Eng Des Sel; 2024 Jan; 37():. PubMed ID: 38757573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DexDesign: A new OSPREY-based algorithm for designing
    Guerin N; Childs H; Zhou P; Donald BR
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95).
    Sharma T; Siddiqi MI
    J Biomol Struct Dyn; 2019 Mar; 37(5):1241-1253. PubMed ID: 29557723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity.
    Roberts KE; Cushing PR; Boisguerin P; Madden DR; Donald BR
    PLoS Comput Biol; 2012; 8(4):e1002477. PubMed ID: 22532795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based identification of CaMKIIα-interacting MUPP1 PDZ domains and rational design of peptide ligands to target such interaction in human fertilization.
    Zhang YL; Han ZF; Sun YP
    Amino Acids; 2016 Jun; 48(6):1509-21. PubMed ID: 26984442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
    Tiwari G; Mohanty D
    PLoS One; 2013; 8(8):e71340. PubMed ID: 23951139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth.
    Khan Z; Terrien E; Delhommel F; Lefebvre-Omar C; Bohl D; Vitry S; Bernard C; Ramirez J; Chaffotte A; Ricquier K; Vincentelli R; Buc H; Prehaud C; Wolff N; Lafon M
    J Biol Chem; 2019 Sep; 294(37):13755-13768. PubMed ID: 31346033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain.
    Amacher JF; Zhao R; Spaller MR; Madden DR
    PLoS One; 2014; 9(8):e103650. PubMed ID: 25136860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway.
    Zheng F; Jewell H; Fitzpatrick J; Zhang J; Mierke DF; Grigoryan G
    J Mol Biol; 2015 Jan; 427(2):491-510. PubMed ID: 25451599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive energetic contributions of multiple peptide positions determine the relative promiscuity of viral and human sequences for PDZ domain targets.
    Tahti EF; Blount JM; Jackson SN; Gao M; Gill NP; Smith SN; Pederson NJ; Rumph SN; Struyvenberg SA; Mackley IGP; Madden DR; Amacher JF
    Protein Sci; 2023 Apr; 32(4):e4611. PubMed ID: 36851847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
    Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
    Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the process of inverted peptides (PIPE
    Seisel Q; Rädisch M; Gill NP; Madden DR; Boisguerin P
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3111-3116. PubMed ID: 28549735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loop.
    Amacher JF; Cushing PR; Bahl CD; Beck T; Madden DR
    J Biol Chem; 2013 Feb; 288(7):5114-26. PubMed ID: 23243314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Specific Peptide-Protein Recognition.
    Zheng F; Grigoryan G
    Methods Mol Biol; 2016; 1414():249-63. PubMed ID: 27094296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster based prediction of PDZ-peptide interactions.
    Kundu K; Backofen R
    BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S5. PubMed ID: 24564547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational design and optimization of novel d-peptide TNFα inhibitors.
    Yang W; Zhang Q; Zhang C; Guo A; Wang Y; You H; Zhang X; Lai L
    FEBS Lett; 2019 Jun; 593(12):1292-1302. PubMed ID: 31102258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting PDZ domain mediated protein interactions from structure.
    Hui S; Xing X; Bader GD
    BMC Bioinformatics; 2013 Jan; 14():27. PubMed ID: 23336252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
    Hoffer L; Roche P; Morelli X
    Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family.
    Nissen KB; Haugaard-Kedström LM; Wilbek TS; Nielsen LS; Åberg E; Kristensen AS; Bach A; Jemth P; Strømgaard K
    PLoS One; 2015; 10(2):e0117668. PubMed ID: 25658767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequence-based computational approach to predicting PDZ domain-peptide interactions.
    Nakariyakul S; Liu ZP; Chen L
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):165-70. PubMed ID: 23608946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.